Internal dosimetry of 99mTc-Androctonus crassicauda scorpion venom complex using MCNP simulation code and MIRD method for cancer diagnostic and therapeutic purposes Internal dosimetry of 99mTc-Androctonus crassicauda scorpion venom
Archives of Advances in Biosciences,
Vol. 12 No. 4 (2021),
12 October 2021
,
Page 50-57
https://doi.org/10.22037/aab.v12i4.35624
Abstract
Introduction: Due to the increasing progress of cancer, the view of paying attention to the rich resources in nature such as animal venom has been considered by researchers due to less side effects than existing treatments. Therefore, the tissue distribution of radionuclide-venom complex in laboratory animals and the internal dosimetry of the organs are of great importance for the clinical diagnostic and therapeutic purposes of cancer.
Methods: In this study, after biological distribution of 99mTc-venom complex and calculation of %ID/g, accumulation activity, dosimetry estimation steps were obtained and human data were extracted from the Sparks-Idogan formula. Then effective dose calculation was performed using MIRD analysis method and MCNP simulation code.
Result: The dose of 99mTc-venom in different organs of the human body was calculated based on the distribution of information in the rat body using the MIRD analysis method and the MCNP simulation code. The highest and the lowest effective dose respectively delivered to the heart wall (with 3.47E-05 and 4.05E-05 mSv/MBq) and the testic(0.05E-06 and 0.08E-06 mSv/MBq).
Conclusion: Considering the antitumor effect of Andro ctonus crassicauda scorpion venom according to recent research, we hope that the results of biological distribution and internal dosimetry 99mTc-venom in this research will be a step the clinical diagnostic and therapeutic purposes of cancer using natural products in the future .
- Internal dosimetry, Androctonus crassicauda scorpion venom,99mTc, MIRD Method, MCNP Simulation Code
How to Cite
References
Siegel RL, Miller KD, Jemal A. Cancer statistics, 2015. CA Cancer J Clin. 2015; 65(1):5-29. [DOI:10.3322/caac.21254] [PMID]
Qi F, Li A, Inagaki Y, Gao J, Li J, Kokudo N, et al. Chinese herbal medicines as adjuvant treatment during chemo- or radio-therapy for cancer. Biosci Trends. 2010; 4(6):297-307. [PMID]
Dunn B. Cancer: Solving an age-old problem. Nature. 2012; 483(7387):S2-6. [DOI:10.1038/483S2a] [PMID]
Sudhakar A. History of cancer, ancient and modern treatment methods. J Cancer Sci Ther. 2009; 1(2):1-4. [DOI:10.4172/1948-5956.100000e2] [PMID]
Kopenhaver J, Carlson RD, Snook AE. Mobilizing toxins for cancer treatment: Historical perspectives and current strategies. Toxins. 2020; 12(6):416. [DOI:10.3390/toxins12060416] [PMID] [PMCID]
Rashidi G, Ghadiri A, Vazirianzade B, Fathi N, Khodadadi A, Rashno M, et al. An in vitro study on cytotoxic effects of Androctonus crassicauda scorpion venom on K562 cell line. Res J Pharm Biol Chem Sci. 2016; 7(6):846-52. https://www.rjpbcs.com/pdf/2016_7(6)/[107].pdf
Heinen TE, da Veiga AB. Arthropod venoms and cancer. Toxicon. 2011; 57(4):497-511. [DOI:10.1016/j.toxicon.2011.01.002] [PMID]
Chaisakul J, Hodgson WC, Kuruppu S, Prasongsook N. Effects of animal venoms and toxins on hallmarks of cancer. J Cancer. 2016; 7(11):1571-8. [DOI:10.7150/jca.15309] [PMID] [PMCID]
Cologna CT, Marcussi S, Giglio JR, Soares AM, Arantes EC. Tityus serrulatus scorpion venom and toxins: An overview. Protein Pept Lett. 2009; 16(8):920-32. [DOI:10.2174/092986609788923329] [PMID]
Radmanesh M. Androctonus crassicauda sting and its clinical study in Iran. J Trop Med Hyg. 1990; 93(5):323-6. [PMID]
Martin-Eauclaire MF, Couraud F. Scorpion neurotoxins: Effects and mechanisms. In: Chang LW, Dyer RS, editors. Handk Neurotoxicology. New York: Marcel Dekker; 1995. pp. 683-716.
Becerril B, Marangoni S, Possani LD. Toxins and genes isolated from scorpions of the genus Tityus. Toxicon. 1997; 35(6):821-35. [DOI:10.1016/S0041-0101(96)00198-5]
Novais CM, Pujatti PB, Castro MAS, Soares MA, De Lima ME, Simal C, et al. 99mTc radiolabeling of crotoxin as a tool for biodistribution studies. J Radioanal Nucl Chem. 2006; 269(3):591-5. [DOI:10.1007/s10967-006-0270-y]
Shirmardi SP, Shamsaei M, Gandomkar M, Ghannadi Maragheh M. Synthesis and biodistribution study of a chlorotoxin derivative peptide labeled with 131- iodine for tumor therapy. Int J Radiat Res. 2011; 8(4):243-8. http://ijrr.com/article-1-687-en.html
Shirmardi SP, Erfani M, Zare Mirakabadi A, Mirzaei HR, Mola M, Pezham MH, et al. Radiolabeling the peptides extracted from scorpion venom (ICD-85) with 99mTc as treatment and imaging agent for cancer. Iran J Med Phys. 2018; 15(Special Issue-12th. Iranian Congress of Medical Physics):357. [DOI:10.22038/IJMP.2018.13021]
Díaz-García A, Pimentel González G, Basaco Bernabeu T, Rodríguez Aurrecochea JC, Rodríguez Sánchez H, Sánchez Monzón I, et al. Pharmacokinetics and biodistribution of Rhopalurus junceus scorpion venom in tumor-bearing mice after intravenous and oral administration. Iran Biomed J. 2019; 23(4):287-96. [DOI:10.29252/ibj.23.4.287] [PMID] [PMCID]
Banerjee S, Pillai MR, Ramamoorthy N. Evolution of Tc-99m in diagnostic radiopharmaceuticals. Semin Nucl Med. 2001; 31(4):260-77. [DOI:10.1053/snuc.2001.26205] [PMID]
Díaz-García A, Morier-Díaz L, Frión-Herrera Y, Rodríguez-Sánchez H, Caballero-Lorenzo Y, Mendoza-Llanes D, et al. In vitro anticancer effect of venom from Cuban scorpion Rhopalurus junceus against a panel of human cancer cell lines. J Venom Res. 2013; 4:5-12. [PMID] [PMCID]
Zargan J, Sajad M, Umar S, Naime M, Ali S, Khan HA. Scorpion (Androctonus crassicauda) venom limits growth of transformed cells (SH-SY5Y and MCF-7) by cytotoxicity and cell cycle arrest. Exp Mol Pathol. 2011; 91(1):447-54. [DOI:10.1016/j.yexmp.2011.04.008] [PMID]
Lahooti A, Shanehsazzadeh S, Jalilian AR, Tavakoli MB. Assessment of effective absorbed dose of 111In-DTPA-Buserelin in human on the basis of biodistribution rat data. Radiat Prot Dosimetry. 2013; 154(1):1-8. [DOI:10.1093/rpd/ncs137] [PMID]
Sparks RB, Aydogan B. Comparison of the effectiveness of some common animal data scaling techniques in estimating human radiation dose. Paper presented at: Conference: 6. International Radiopharmaceutical Dosimetry Symposium. 7-10 May 1996; Gatlinburg, TN, United States. https://www.osti.gov/biblio/684479
Lahooti A, Shanehsazzadeh S, Oghabian MA, Allen BJ. Assessment of human effective absorbed dose of Tc-99m-USPIO based on biodistribution rat data. J Labelled Comp Radiopharm. 2013; 56:S258. https://www.researchgate.net/publication/246044640
Shanehsazzadeh S, Lahooti A, Sadeghi HR, Jalilian AR. Estimation of human effective absorbed dose of 67Ga-cDTPA-gonadorelin based on biodistribution rat data. Nucl Med Commun. 2011; 32(1):37-43. [DOI:10.1097/MNM.0b013e328340b916] [PMID]
Shanehsazzadeh S, Lahooti A, Shirmardi SP, Erfani M. Comparison of estimated human effective dose of 67Ga- and 99mTc-labeled bombesin based on distribution data in mice. J Radioanal Nucl Chem. 2015; 305(2):513-20. [DOI:10.1007/s10967-015-3995-7]
Valentin J. Radiation dose to patients from radiopharmaceuticals: (Addendum 2 to ICRP publication 53) ICRP publication 80 approved by the commission in September 1997. Ann ICRP. 1998; 28(3):1. [DOI:10.1016/S0146-6453(99)00006-8]
Lazarine AD. Medical physics calculations with MCNP: A primer. College Station, TX: Texas A & M University; 2006. https://books.google.com/books?id=xCLtjwEACAAJ&dq
No Authors Listed. Age-dependent doses to members of the public from intake of radionuclides: Part 5. Compilation of ingestion and inhalation dose coefficients. Ann ICRP. 1996; 26(1):1-91. [DOI:10.1016/s0146-6453(00)89192-7] [PMID]
Bacher K, Thierens HM. Accurate dosimetry: An essential step towards good clinical practice in nuclear medicine. Nucl Med Commun. 2005; 26(7):581-6. [DOI:10.1097/01.mnm.0000169204.13754.e2] [PMID]
Shen S, Khazaeli MB, Gillespie GY, Alvarez VL. Radiation dosimetry of 131I-chlorotoxin for targeted radiotherapy in glioma-bearing mice. J Neurooncol. 2005; 71(2):113-9. [DOI:10.1007/s11060-004-0890-4] [PMID]
de Andrade HM, Ferreira AV, Soprani J, de Figueiredo SG, dos Santos RG. 131I-SPGP internal dosimetry: Animal model and human extrapolation. Paper presented at: International Nuclear Atlantic Conference - INAC 2009. 27 September - 2 October 2009; Rio de Janeiro, RJ, Brazil. https://inis.iaea.org/collection/NCLCollectionStore/_Public/40/106/40106324.pdf
- Abstract Viewed: 366 times
- PDF Downloaded: 151 times